Efficacy and safety of a dual boosted protease inhibitor-based regimen, atazanavir and fosamprenavir/ritonavir, against HIV: experience in a pediatric population

BACKGROUND: Although dual-boosted protease inhibitors regimen is not recommended in children with HIV infection, such a strategy could be useful in subjects with a complex resistance profile. This study was aimed at assessing the long term efficacy and safety of a double-boosted protease inhibitor c...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Rusconi, Stefano, Giacomet, Vania, Mameli, Chiara, Viganò, Alessandra, Viganò, Ottavia, Adorni, Fulvio, Galli, Massimo, Zuccotti, Gian Vincenzo
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2012
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3434076/
https://ncbi.nlm.nih.gov/pubmed/22866946
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2334-12-179
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы